Cargando…

In Silico Discovery of Anticancer Peptides from Sanghuang

Anticancer peptide (ACP) is a short peptide with less than 50 amino acids that has been discovered in a variety of foods. It has been demonstrated that traditional Chinese medicine or food can help treat cancer in some cases, which suggests that ACP may be one of the therapeutic ingredients. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Minghao, Lv, Jiachen, Chen, Liyuan, Li, Wannan, Han, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693127/
https://www.ncbi.nlm.nih.gov/pubmed/36430160
http://dx.doi.org/10.3390/ijms232213682
_version_ 1784837457323229184
author Liu, Minghao
Lv, Jiachen
Chen, Liyuan
Li, Wannan
Han, Weiwei
author_facet Liu, Minghao
Lv, Jiachen
Chen, Liyuan
Li, Wannan
Han, Weiwei
author_sort Liu, Minghao
collection PubMed
description Anticancer peptide (ACP) is a short peptide with less than 50 amino acids that has been discovered in a variety of foods. It has been demonstrated that traditional Chinese medicine or food can help treat cancer in some cases, which suggests that ACP may be one of the therapeutic ingredients. Studies on the anti-cancer properties of Sanghuangporus sanghuang have concentrated on polysaccharides, flavonoids, triterpenoids, etc. The function of peptides has not received much attention. The purpose of this study is to use computer mining techniques to search for potential anticancer peptides from 62 proteins of Sanghuang. We used mACPpred to perform sequence scans after theoretical trypsin hydrolysis and discovered nine fragments with an anticancer probability of over 0.60. The study used AlphaFold 2 to perform structural modeling of the first three ACPs discovered, which had blast results from the Cancer PPD database. Using reverse docking technology, we found the target proteins and interacting residues of two ACPs with an unknown mechanism. Reverse docking results predicted the binding modes of the ACPs and their target protein. In addition, we determined the active part of ACPs by quantum chemical calculation. Our study provides a framework for the future discovery of functional peptides from foods. The ACPs discovered have the potential to be used as drugs in oncology clinical treatment after further research.
format Online
Article
Text
id pubmed-9693127
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96931272022-11-26 In Silico Discovery of Anticancer Peptides from Sanghuang Liu, Minghao Lv, Jiachen Chen, Liyuan Li, Wannan Han, Weiwei Int J Mol Sci Article Anticancer peptide (ACP) is a short peptide with less than 50 amino acids that has been discovered in a variety of foods. It has been demonstrated that traditional Chinese medicine or food can help treat cancer in some cases, which suggests that ACP may be one of the therapeutic ingredients. Studies on the anti-cancer properties of Sanghuangporus sanghuang have concentrated on polysaccharides, flavonoids, triterpenoids, etc. The function of peptides has not received much attention. The purpose of this study is to use computer mining techniques to search for potential anticancer peptides from 62 proteins of Sanghuang. We used mACPpred to perform sequence scans after theoretical trypsin hydrolysis and discovered nine fragments with an anticancer probability of over 0.60. The study used AlphaFold 2 to perform structural modeling of the first three ACPs discovered, which had blast results from the Cancer PPD database. Using reverse docking technology, we found the target proteins and interacting residues of two ACPs with an unknown mechanism. Reverse docking results predicted the binding modes of the ACPs and their target protein. In addition, we determined the active part of ACPs by quantum chemical calculation. Our study provides a framework for the future discovery of functional peptides from foods. The ACPs discovered have the potential to be used as drugs in oncology clinical treatment after further research. MDPI 2022-11-08 /pmc/articles/PMC9693127/ /pubmed/36430160 http://dx.doi.org/10.3390/ijms232213682 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Minghao
Lv, Jiachen
Chen, Liyuan
Li, Wannan
Han, Weiwei
In Silico Discovery of Anticancer Peptides from Sanghuang
title In Silico Discovery of Anticancer Peptides from Sanghuang
title_full In Silico Discovery of Anticancer Peptides from Sanghuang
title_fullStr In Silico Discovery of Anticancer Peptides from Sanghuang
title_full_unstemmed In Silico Discovery of Anticancer Peptides from Sanghuang
title_short In Silico Discovery of Anticancer Peptides from Sanghuang
title_sort in silico discovery of anticancer peptides from sanghuang
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693127/
https://www.ncbi.nlm.nih.gov/pubmed/36430160
http://dx.doi.org/10.3390/ijms232213682
work_keys_str_mv AT liuminghao insilicodiscoveryofanticancerpeptidesfromsanghuang
AT lvjiachen insilicodiscoveryofanticancerpeptidesfromsanghuang
AT chenliyuan insilicodiscoveryofanticancerpeptidesfromsanghuang
AT liwannan insilicodiscoveryofanticancerpeptidesfromsanghuang
AT hanweiwei insilicodiscoveryofanticancerpeptidesfromsanghuang